Evaluation of humoral immune response in relation to COVID-19 severity over 1 year post-infection: critical cases higher humoral immune response than mild cases.

Bang, Mi-Seon; Kim, Choon-Mee; Cho, Nam-Hyuk; Seo, Jun-Won; Kim, Da Young; Yun, Na Ra; Kim, Dong-Min

Bang, Mi-Seon; Kim, Choon-Mee; Cho, Nam-Hyuk; Seo, Jun-Won; Kim, Da Young; Yun, Na Ra; Kim, Dong-Min.

Affiliation

Bang MS; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Kim CM; Premedical Science, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Cho NH; Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Seo JW; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Kim DY; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Yun NR; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Kim DM; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.

Front Immunol ; 14: 1203803, 2023.

Article de En | MEDLINE | ID: mdl-37545518

Sujet(s)
Mots clés

1-year follow-up; COVID-19; antibody response; neutralization potency; neutralizing antibody; severe acute respiratory syndrome coronavirus 2

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Immunité humorale / COVID-19 Limites: Humans Langue: En Journal: Front Immunol Année: 2023 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google